Upstream Bio (UPB) Operating Margin (2023 - 2025)
Historic Operating Margin for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to 5539.39%.
- Upstream Bio's Operating Margin fell 24268600.0% to 5539.39% in Q3 2025 from the same period last year, while for Sep 2025 it was 5020.08%, marking a year-over-year decrease of 20397400.0%. This contributed to the annual value of 3281.18% for FY2024, which is 15957200.0% down from last year.
- According to the latest figures from Q3 2025, Upstream Bio's Operating Margin is 5539.39%, which was down 24268600.0% from 4732.87% recorded in Q2 2025.
- Over the past 5 years, Upstream Bio's Operating Margin peaked at 1511.43% during Q3 2023, and registered a low of 5656.01% during Q1 2025.
- For the 3-year period, Upstream Bio's Operating Margin averaged around 3757.22%, with its median value being 3439.22% (2024).
- Its Operating Margin has fluctuated over the past 5 years, first tumbled by -11088700bps in 2024, then plummeted by -33102300bps in 2025.
- Quarter analysis of 3 years shows Upstream Bio's Operating Margin stood at 3184.44% in 2023, then tumbled by -35bps to 4293.31% in 2024, then dropped by -29bps to 5539.39% in 2025.
- Its Operating Margin was 5539.39% in Q3 2025, compared to 4732.87% in Q2 2025 and 5656.01% in Q1 2025.